NeuBase Therapeutics, Inc. Increase Decrease In Operating Lease Liability
NeuBase Therapeutics, Inc. reported Increase Decrease In Operating Lease Liability of -$348.03 thousand for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2023-11-09
- NeuBase Therapeutics, Inc. increase decrease in operating lease liability for the quarter ending 2023-09-30 was -$118.90K.
- NeuBase Therapeutics, Inc. increase decrease in operating lease liability for the quarter ending 2023-06-30 was -$116.18K.
- NeuBase Therapeutics, Inc. increase decrease in operating lease liability for the quarter ending 2023-03-31 was -$112.94K.
- NeuBase Therapeutics, Inc. increase decrease in operating lease liability for the quarter ending 2022-12-31 was -$120.01K.
- NeuBase Therapeutics, Inc. increase decrease in operating lease liability for fiscal 2022 was -$453.06K, a 869.21% decline from fiscal 2021.
- NeuBase Therapeutics, Inc. increase decrease in operating lease liability for fiscal 2021 was $58.90K.
- NeuBase Therapeutics, Inc. increase decrease in operating lease liability for fiscal 2020 was $0.00.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2023-09-30 | -$118.90K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$235.09K derived: sum of 2 quarters · filed 2023-11-09 | -$348.03K 10-Q · filed 2023-11-09 | -$468.04K derived: sum of 4 quarters · filed 2023-11-09 |
| 2023-06-30 | -$116.18K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$229.12K 10-Q · filed 2023-08-14 | -$349.13K derived: sum of 3 quarters · filed 2023-08-14 | -$484.95K derived: sum of 4 quarters · filed 2023-11-09 |
| 2023-03-31 | -$112.94K 10-Q · filed 2023-05-11 | -$232.95K derived: sum of 2 quarters · filed 2023-06-05 | -$368.77K derived: sum of 3 quarters · filed 2023-11-09 | -$501.47K derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-12-31 | -$120.01K 10-QT · filed 2023-06-05 | -$255.83K derived: sum of 2 quarters · filed 2023-11-09 | -$388.53K derived: sum of 3 quarters · filed 2023-11-09 | -$509.09K derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-09-30 | -$135.82K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$268.52K derived: sum of 2 quarters · filed 2023-11-09 | -$389.08K 10-Q · filed 2023-11-09 | -$453.06K 10-K · filed 2022-12-21 |
| 2022-06-30 | -$132.70K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$253.26K 10-Q · filed 2023-08-14 | -$317.24K 10-Q · filed 2022-08-11 | -$317.15K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | -$120.56K 10-Q · filed 2023-05-11 | -$184.54K 10-Q · filed 2022-05-12 | -$184.45K derived: sum of 3 quarters · filed 2023-06-05 | -$125.64K derived: sum of 4 quarters · filed 2023-06-05 |
| 2021-12-31 | -$63.97K 10-QT · filed 2023-06-05 | -$63.88K derived: sum of 2 quarters · filed 2023-06-05 | -$5.07K derived: sum of 3 quarters · filed 2023-06-05 | -$5.07K derived: sum of 4 quarters · filed 2023-06-05 |
| 2021-09-30 | $90.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-12-21 | $58.90K derived: sum of 2 quarters · filed 2022-12-21 | $58.90K derived: sum of 3 quarters · filed 2022-12-21 | $58.90K 10-K · filed 2022-12-21 |
| 2021-06-30 | $58.81K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-08-11 | $58.81K derived: sum of 2 quarters · filed 2022-08-11 | $58.81K 10-Q · filed 2022-08-11 | |
| 2021-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-05-12 | $0.00 10-Q · filed 2022-05-12 | ||
| 2020-12-31 | $0.00 10-Q · filed 2022-02-11 | |||
| 2020-09-30 | $0.00 10-K · filed 2021-12-23 |